Detalles de la búsqueda
1.
Esr1 but Not CYP19A1 Overexpression in Mammary Epithelial Cells during Reproductive Senescence Induces Pregnancy-Like Proliferative Mammary Disease Responsive to Anti-Hormonals.
Am J Pathol
; 193(1): 84-102, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464512
2.
Overexpression of Estrogen Receptor α in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor α-Positive Mammary Adenocarcinomas.
Am J Pathol
; 193(1): 103-120, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464513
3.
Mouse Mammary Gland Whole Mount Density Assessment across Different Morphologies Using a Bifurcated Program for Image Processing.
Am J Pathol
; 192(10): 1407-1417, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36115719
4.
The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ.
Breast Cancer Res Treat
; 169(1): 47-57, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29350308
5.
Immune transcriptome and antibody response in adult-onset Still's disease with mild flare following administration of mRNA vaccine BNT162b2.
Rheumatology (Oxford)
; 61(10): e305-e307, 2022 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35532082
6.
Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
Carcinogenesis
; 36(1): 122-32, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25421723
7.
Oestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland.
Dev Biol
; 391(2): 219-29, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24769368
8.
The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers.
Mol Carcinog
; 54(10): 1172-80, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25043748
9.
The PPARγ agonist efatutazone increases the spectrum of well-differentiated mammary cancer subtypes initiated by loss of full-length BRCA1 in association with TP53 haploinsufficiency.
Am J Pathol
; 182(6): 1976-85, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23664366
10.
Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections.
iScience
; 27(3): 109177, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38414855
11.
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2.
Sci Rep
; 14(1): 2808, 2024 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307916
12.
Variant- and Vaccination-Specific Alternative Splicing Profiles in SARS-CoV-2 Infections.
bioRxiv
; 2023 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38076812
13.
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2.
bioRxiv
; 2023 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38076885
14.
Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination.
Blood Adv
; 7(10): 2214-2227, 2023 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36630562
15.
circRNA-sponging: a pipeline for extensive analysis of circRNA expression and their role in miRNA sponging.
Bioinform Adv
; 3(1): vbad093, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37485422
16.
Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research.
Cells
; 12(19)2023 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830602
17.
Network medicine-based epistasis detection in complex diseases: ready for quantum computing.
medRxiv
; 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38076997
18.
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients.
medRxiv
; 2022 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441161
19.
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients.
iScience
; 25(11): 105369, 2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36267551
20.
Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron.
iScience
; 25(6): 104473, 2022 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35637788